Evidence map›Paper›PMID 29680823›Full record

ArticleJournal of the American Heart Association2018

Prodomain of Furin Promotes Phospholipid Transfer Protein Proteasomal Degradation in Hepatocytes.

Yang Yu, Xia Lei, Hui Jiang, Zhiqiang Li, John W M Creemers, Ming Zhang, Shucun Qin, Weijun Jin, Xian-Cheng Jiang

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Yang YuDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Xia LeiDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Hui JiangDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Zhiqiang LiDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
John W M CreemersLaboratory of Biochemical Neuroendocrinology, Department of Human Genetics, Herestraat 49 bus 602, 3000 Leuven, Belgium.
Ming ZhangDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Shucun QinKey Laboratory of Atherosclerosis in Universities of Shandong and Institute of Atherosclerosis, Taishan Medical University, Taian, China xjiang@downstate.edu shucunqin@hotmail.com.
Weijun JinDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Xian-Cheng JiangDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY xjiang@downstate.edu shucunqin@hotmail.com.
State University of New York · USSUNY Downstate Health Sciences University · USKU Leuven · BETaishan Medical University · CNVA NY Harbor Healthcare System · US

Funding

The role of PLTP in BLp metabolism and atherogenesisR01HL069817 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG · 2002 to 2010
$2.6M
Hepatic PLTP as a target for lowering LDL-cR56HL121409 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG, JIN, WEIJUN · 2014 to 2014
$400k
BLRD VA I01 BX000900NHLBI NIH HHS R01 HL069817NHLBI NIH HHS R56 HL121409RRD VA I01 RX000900
6 · The paper itself

Abstract

backgroundPhospholipid transfer protein (PLTP) is one of the major modulators of lipoprotein metabolism and atherosclerosis development; however, little is known about the regulation of PLTP. The effect of hepatic prodomain of furin (profurin) expression on PLTP processing and function is investigated. METHODS AND

resultsWe used adenovirus expressing profurin in mouse liver to evaluate PLTP activity, mass, and plasma lipid levels. We coexpressed PLTP and profurin in human hepatoma cell line cells and studied their interaction. We found profurin expression significantly reduced plasma lipids, plasma PLTP activity, and mass in all tested mouse models, compared with controls. Moreover, the expression of profurin dramatically reduced liver PLTP activity and protein level. We further explored the mechanism using in vivo and ex vivo approaches. We found that profurin can interact with intracellular PLTP and promote its ubiquitination and proteasomal degradation, resulting in less PLTP secretion from the hepatocytes. Furin does not cleave PLTP; instead, it forms a complex with PLTP, likely through its prodomain.

conclusionsOur study reveals that hepatic PLTP protein is targeted for proteasomal degradation by profurin expression, which could be a novel posttranslational mechanism underlying PLTP regulation.

Indexed as

AnimalsAtherosclerosisCell Line, TumorDisease Models, AnimalFurinHepatocytesHumansLipidsMaleMice, Inbred C57BLMice, Knockout, ApoEPhospholipid Transfer ProteinsProteasome Endopeptidase ComplexProtein BindingProtein Interaction Domains and MotifsProteolysisFurinFURIN protein, humanLipidsphospholipid transfer protein, mousePhospholipid Transfer ProteinsPLTP protein, humanProteasome Endopeptidase ComplexReceptors, LDLatherosclerosisfurin (PCSK3)lipids and lipoprotein metabolismphospholipid transfer proteinprofurinproteasome

Identifiers

PMID29680823
PMCPMC6015287
OpenAlexW2799842851

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.